The Resonance Health Limited (ASX: RHT) share price has been placed in a trading halt. This comes after an announcement by the company this afternoon. Prior to the halt, the Resonance Health share price was trading narrowly higher. Rising to 19.5 cents, up by 2.63%.

The Resonance Health share price has been a poor performer so far this year, shedding 15%. Let’s take a closer look at what this means for the company.  

What Resonance Health does

Resonance Health is an Australian healthcare company. It is involved in the development and delivery of non-invasive medical imaging software and services. Resonance Health’s products are used by clinicians in the diagnosis and management of human diseases. Its products are also used by pharmaceutical companies in their clinical trials.

The Company’s flagship product is its HepaFat-AI technology. This gained FDA approval earlier this year. The FDA approval which paves the way for commercialisation of the technology sent its shares 80% higher on the day.

HepaFat-AI results can be used to monitor liver fat content in patients undergoing weight loss management. Additionally, it can aid in the assessment and screening of living donors for liver transplants.

What Happened?

This afternoon, the Resonance Health share price is at a standstill. This is due to the company announcing that it would be entering a trading halt. Shares in the company will not begin trading until February 19 or when the announcement is made. Whichever is earliest.

The small cap share requested a trading halt pending the announcement in relation to regulatory approval that affects the company’s share price. With the trading halt now in effect, shareholders will be eagerly awaiting the release of any news.

About the Resonance share price

It has been a volatile 6 months for Resonance Health. Consequently, its share price has jumped between 13.5 and 32.5 cents. Nonetheless, shares in the company are currently trading at a price of 19.5 cents. This is despite having dropped lower since the start of the year.

Resonance Health currently boasts a market capitalisation of $87 million.

More reading

• Pilbara Minerals (ASX:PLS) share price jumps 6% on broker upgrades
• What’s going on with the Cirralto (ASX:CRO) share price?
• 2 high-yielding ASX 200 shares
• Why the InvoCare (ASX:IVC) share price tumbled 5% lower today
• What’s the go with the EarlyPay (ASX:EPY) share price today?

Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Resonance Health Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Resonance Health (ASX:RHT) announces its share price is in trading halt appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/37m2q5L

The Cirralto Ltd (ASX: CRO) share price is on fire again today, climbing another 21% at the time of writing to 12 cents a share. That move is nothing to what Cirralto shares did this morning at market open though.

The Cirralto share price had closed at 9.8 cents yesterday afternoon after recording a sizable 30% rise over the day. But this morning, it opened at 16 cents a share and shot up as high as 21 cents. That represents a 114% rise over yesterday’s closing price.

As we reported yesterday (and which remains unchanged today), there has been no major news out of the company that might clearly cause such a dramatic move in the share price.

However, saying that, ASX data shows that the trading volume for Cirralto shares remains off the charts. Last Thursday and Friday saw 13.7 million and 17.5 million shares in the company change hands respectively. Yesterday, 352.5 million shares were traded. Today, the number is standing at 283.4 million shares at the time of writing.

Cirralto: Yet another ASX speeding ticket

These moves have drawn the attention of the ASX itself. Yesterday afternoon, the stock market operator issued a ‘please explain’ speeding ticket to Cirralto in response to the massive surge in share price and trading volume. Asked if the company had any idea why this was happening, Cirralto responded by stating:

The company notes recent market, social media and investor focus on ASX listed companies that have technologies associated with payment and merchant services.Other companies in the sector such as Openpay Group, Ioupay Ltd and Zip Co Ltd appear to have also experienced recent material share price increases.

This is true. Zip Co Ltd (ASX: Z1P), Openpay Group Ltd (ASX: OPY) and IOUpay Ltd (ASX: IOU) have all experienced similar moves over the week so far. The ASX has issued Zip and IOUpay with speeding tickets this week as well. Both companies have also denied any knowledge of any possible cause behind the dramatic spikes.

More reading

• The Cirralto (ASX:CRO) share price is hitting 52-week highs today

Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of ZIPCOLTD FPO. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post What’s going on with the Cirralto (ASX:CRO) share price? appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3bapyFn

High-yielding S&P/ASX 200 Index (ASX: XJO) shares could be interesting in a world where many bank accounts offer a lower interest rate than the current rate of inflation.

The ASX 200 is full of businesses that have been running for many years and may be among the leaders in their industry in Australia or whichever location(s) they operate.

The below two ASX shares are on track to pay dividend yields of comfortably more than 5% in FY21.

APA Group (ASX: APA)

This ASX 200 share describes itself as a leading Australian energy infrastructure business. It owns and/or operates around $22 billion of energy infrastructure assets. APA boasts that its gas transmission pipelines span every state and territory on mainland Australia, delivering approximately half of the nation’s gas usage.

APA was one of the few ASX 200 businesses to increase its dividend, or distribution in APA’s case, during the COVID-19-affected year of 2020. Indeed, it has actually grown its distribution every year for a decade and a half.

In the FY20 result it grew its annual distribution by 6.4% to 50 cents per security, which was funded by an 8.3% increase in operating cashflow and a rise in net profit after tax (NPAT) of 10.1%.

APA said that the FY20 result demonstrated the strength and stability of its asset portfolio and low risk business fundamentals. Management also said that the balance sheet was in very good shape.

The ASX 200 share is currently looking at the US as an attractive opportunity, but its most recently announced energy projects are based in Australia.

In November 2020, APA announced a $460 million investment to build the Northern Goldfield Interconnect (NGI) to link with APA’s Goldfields Gas Pipeline (GGP) which in turn connects with APA’s Eastern Goldfields network, creating an interconnected pipeline which covers 2,690km from north to south and west to east.

APA thinks that with the depth and mix of projects expected to be delivered in this region, it expects the NGI will have a strong portfolio of long-term contracts in place by the time construction is complete in the middle of 2022.

After a 4.3% increase to the FY21 interim distribution, APA has a current yield of 5.5%

Charter Hall Long WALE REIT (ASX: CLW)

This is a ASX 200 dividend share that’s liked by a few different brokers right now including Morgan Stanley and Citi.

The concept of the real estate investment trust (REIT) is that it is invested in properties with high quality tenants on contracts with long tenancy agreements. At the end of December 2020, the weighted average lease expiry (WALE) had risen slightly to 14.1 years – up from 14 years.

Morgan Stanley said that the FY21 first half-year result was good, it was better than the broker was expecting. Citi thinks that the rest of the 2021 financial year looks positive because of the approximately $700 million of acquisitions that the REIT has made recently.

Two of those asset acquisitions have been the flagship David Jones store in Sydney and a portfolio of BP locations in New Zealand. Another acquisition by the ASX 200 share was spending $281.5 million on the Telstra Corporation Ltd (ASX: TLS) telephone exchange and data centre located at 76 to 78 Pitt Street in Sydney.

At the end of the half-year period, Charter Hall Long WALE REIT had an occupancy rate of 97.5% across 459 properties.

In the half-year report it grew the distribution by 3.6% year on year to 14.5 cents per security. The FY21 distribution is expected to be at least 29.1 cents. At the current Charter Hall Long WALE REIT share price, that translates to a distribution yield of 6.2%.

More reading

• Why the Evolution (ASX:EVN) share price crashed despite record results
• 5 things to watch on the ASX 200 on Wednesday
• The latest ASX shares upgraded by brokers to “buy” during the reporting season
• ASX 200 rises 0.7%, Redbubble sinks, BHP dividend jumps
• NRW (ASX:NWH) share price jumps on acquisition update

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Telstra Limited. The Motley Fool Australia owns shares of APA Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post 2 high-yielding ASX 200 shares appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/37lFaEU

The InvoCare Limited (ASX: IVC) share price was a poor performer on Wednesday.

The funerals company’s shares sank as much as 5% before ending the day almost 4% lower at $10.83.

Why did the InvoCare share price tumble lower?

Investors were selling InvoCare shares on Wednesday following the release of an announcement relating to its upcoming full year results.

According to the release, the company intends to recognise $26.5 million in pre-tax significant items in its FY 2020 financial results. This comprises $7 million worth of operating items and $19.5 million of non-operating items.

In light of this, InvoCare expects to report a disappointing net loss after tax in the range of $7 million to $12 million.

It is also worth noting that even excluding its significant items, InvoCare would still be reporting a material profit decline.

Excluding these significant items, net profit after tax is expected in the range of $14 million to $19 million. This represents a 70% to 78% decline on FY 2020’s net profit after tax of $63.8 million. Though, it is worth noting that the prior period does include a mark-to-market gain on the revaluation of undelivered prepaid contracts.

What are the significant items?

The release explains that a material portion of the significant items is linked to the softening of the funeral services sector in Australia and New Zealand.

It notes that this is being primarily driven by a range of impacts flowing from the COVID-19 pandemic.

The company commented: “Goodwill related to the New Zealand business (which represents less than 10% of Group operating EBITDA) was impaired by $24.4 million in the 2019 financial year. While some progress had been made to improve the business, the reassessment of recoverable value will result in a further $19.3 million goodwill impairment for the year ended 31 December 2020. Notwithstanding the impairment, the Group remains confident that the quality of our frontline team in New Zealand will continue to provide excellent service to our client families.”

What else?

In addition to this, it advised that some of the significant items relate to the carrying value assessments performed as part of year-end accounting procedures or are items that provide disclosure clarity to operating earnings.

This includes a $6.2 million impairment to the carrying value of certain modules of the Oracle ERP project. It advised that the replacement of certain functions rendered some elements of the IT platform obsolete.

InvoCare intends to release its full year results on 24 February.

More reading

• GameStop effect: 3 more shorted ASX shares that could skyrocket
• ASX 200 down 0.2%: Zip Chair steps down, Worley crashes, Blackmores & InvoCare jump
• Here are the 10 most shorted shares on the ASX
• Are InvoCare (ASX:IVC) shares the ASX version of GameStop?
• ASX 200 down 2.3%: Bank shares tumble, InvoCare jumps, IOOF disappoints

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended InvoCare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the InvoCare (ASX:IVC) share price tumbled 5% lower today appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3u5d8Hp

The EarlyPay Ltd (ASX: EPY) share price has been a rollercoaster today. Initially, shares in the non-bank lender jumped on open to 50 cents, an increase of 16%. Celebrations were short-lived with the shares taking the elevator back to 44 cents.

The price movements are cause for some head-scratching, as there are no announcements. Let’s take a look at what could be happening.

What might be moving the EarlyPay share price?

EarlyPay rebranding resonates with rocketeers

EarlyPay was previously known as CML Group – just doesn’t have the same ring to it, does it? The recent rebranding was a part of the company’s shift towards a new software-as-a-service (SaaS) operation after acquiring Skippr.

Transitioning to more of a digital-leaning lender, EarlyPay likely hopes to replicate the success of ASX-listed Wisr Ltd (ASX: WZR) in its digital endeavours. EarlyPay does differ from Wisr though, as the former provides secured finance to small and medium-sized businesses. Whereas Wisr offers loans to individuals for travel, car purchase, etc.

With the acquisition of Skippr, EarlyPay can now assess credit quality through integration with cloud accounting data automatically. Additionally, the whole onboarding process for a customer is now automated – significantly reducing the time and effort required on EarlyPay’s end to facilitate a loan.

There is the potential that some are speculating over the name EarlyPay, as it sounds a little like Afterpay Ltd (ASX: APT). With the buy now, pay later (BNPL) sector heating up, everyone is hunting for new entrants. However, EarlyPay isn’t quite a BNPL company – although the debate rages on whether BNPL is just glorified credit.

EarlyPay profitable growth play

Investors could also be enticed recently by the fact EarlyPay is profitable. As a consequence of the recent SaaS shift, the company may be appealing to investors less fancied with loss-making businesses.

In its October 2020 investor presentation, EarlyPay recorded $8.4 million in profits on $47.5 million revenue. Based on today’s valuation, that gives EarlyPay a P/E ratio of 11.85 – which would be considered low for a technology company. But, then the debate arises, is it a technology company or just a lender?

Whatever the answer, the EarlyPay share price has had a whirlwind day. At the time of writing, EarlyPay shares are swapping hands for 44 cents, which puts it up 1.16% today and 14% for the year so far. 

More reading

• One year on and 50% up, the All Technology Index is booming
• What’s with the Afterpay (ASX:APT) share price fall today?
• Why is the Splitit (ASX:SPT) share price underperforming Afterpay and Zip?
• The Cirralto (ASX:CRO) share price is hitting 52-week highs today
• Zip (ASX:Z1P) share price is soaring 13%, smashing another record high

Motley Fool contributor Mitchell Lawler owns shares of AFTERPAY T FPO. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post What’s the go with the EarlyPay (ASX:EPY) share price today? appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3dk1K4t

Bitcoin (CRYPTO: BTC) just hit another new record high. And as we humans like to put more weight on nice base-10 numbers (thanks fingers), this is a big one.

The world’s largest cryptocurrency topped US$50,000 in the last 24 hours, peaking at US$50,580. It’s since retraced a bit, to the current price of US$49,500. That’s up some 70% in 2021 alone.

Isn’t Bitcoin just a fad?

For many investors, cryptocurrencies like Bitcoin appear to be little more than a fad. One that will eventually fade away, leaving holders of the digital tokens empty-handed.

But the recent adoption by larger institutions – including the US$1.5 billion investment by Elon Musk’s Tesla Inc (NASDAQ: TSLA) – is shaking the naysayers’ resolve.

According to Eleanor Creagh, Australian market strategist at Saxo Capital Markets, fading trust in institutions is driving the renewed appetite for Bitcoin:

Bitcoin was birthed in the aftermath of the GFC as a currency free from the corruption of central banks and governments, so it’s unsurprising to see renewed interest during a period when central banks’ unconventional monetary policies are highlighting many of the issues Bitcoin sought to solve.

Creagh says mainstream investors are increasingly accepting the current economic and financial models are flawed.

Much as in the wake of the 2008 financial crisis, we are seeing intervention and unconventional monetary policy acting as dual forces that serve to entrench and aggravate inequality. Once again, inequities within our systems are in full view, with a “K-shaped” recovery increasing the wealth transfer to those already asset rich.

Bitcoin meanwhile is designed to function on a standalone basis. It is uncorrupted by banks and governments and therefore immune to the debasement suffered by fiat currencies.

Born from easy money policies

Creagh points the finger at central bank and government’s turning their backs on orthodoxy themselves, with “unbridled liquidity injections and ever-expanding central bank balance sheets” diminishing mainstream scepticism of cryptocurrencies.

Bitcoin’s capped supply at 21 million and non-inflationary model adds to its appeal as a debasement hedge and store of value within this regime, where governments and central banks have stimulus spigots on full force. In addition, the asset possesses a unique quality of an embedded call option on the future should it become a dominant digital monetary network. 

She says that high-profile investors and large asset managers like Blackrock, Morgan Stanley and Guggenheim have helped drive the Bitcoin price higher and increased the general public’s acceptance of the digital token.

Creagh concludes that “In the long term, institutional and commercial support will further validate the cryptocurrency, increasing its popularity as a store of value and paving the path toward mass adoption.”

More reading

• Why the Fatfish (ASX:FFG) share price is diving 21% today
• Tesla stock split: Is another one coming?
• DigitalX (ASX:DCC) share price soars 18% following Bitcoin update
• Why investors should look beyond the ASX 200 to US share markets
• Why I’m never selling my Square shares

Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Tesla. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Bitcoin hits record high: Why Saxo says the cryptocurrency is here to stay appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3s06aBB

Vulcan Energy Resources Ltd (ASX: VUL) shares are sliding in late afternoon trade. At the time of writing, the Vulcan share price is slumping 2.7% to $7.21.

This comes despite the company announcing a collaboration with DuPont Water Solutions to advance its zero-carbon lithium extraction operations. Under the umbrella of one of the world’s largest chemical companies, DuPont Water Solutions specialises in purification and specialty-separation technologies. The company operates on a global scale delivering sustainable methods of water management.

What did Vulcan announce?

The Vulcan share price is trending lower despite the company releasing the positive announcement soon after market open this morning. 

According to its release, the partnership with DuPont is designed to assist Vulcan with achieving the world’s first zero-carbon lithium extraction.

Under the agreement, DuPont will supply direct lithium extraction (DLE) products that will test and scale-up the extraction process. This will include lithium selective sorbent, nanofiltration, reverse osmosis, ion exchange resins, ultrafiltration, and close-circuit reverse osmosis.

DuPont will conduct input and test-work during Vulcan’s zero-carbon lithium project definitive feasibility study (DFS).

The latest deal is another positive push for Vulcan’s efforts to accelerate the development of its project. The company noted that acquiring DLE products from a major supplier will minimise the technical risks associated with the extraction process.

Management commentary

Vulcan Managing Director Dr Francis Wedin touched on the partnership agreement, saying:

Collaborating with a company like DuPont is an important de-risking strategy for the DLE component of our Zero Carbon Lithium project. DuPont’s diverse set of products which can be manufactured at scale are likely to be well-suited to sustainably extract the lithium from the brine.

We look forward to a successful long-term relationship with DuPont, to implement our strategy of becoming a major supplier of our unique Zero Carbon Lithium hydroxide to the European electric vehicle battery market.

DuPont Global Vice President and General Manager HP Nanda went on to add:

We are proud to bring our expertise in water filtration and purification to Vulcan Energy’s Zero Carbon Lithium project to minimise the carbon and water footprint of lithium extraction and production — to more sustainably power mobility for years to come.

Update on the Vulcan share price

It has been an interesting few months for the Vulcan share price, particularly since the start of the year. Vulcan shares have risen to astronomical highs lately, gaining nearly 160% year to date.

While Vulcan shares are sliding today, numerous positive company updates, as well as strong investor sentiment surrounding the lithium industry, have helped push its shares higher in 2021.

Based on the current share price, Vulcan has a market capitalisation of roughly $775 million.

More reading

• Why the Vulcan Energy (ASX:VUL) share price is charging higher again
• Why the Vulcan (ASX:VUL) share price is storming higher today
• ASX 200 falls 0.9%, Nick Scali reports, Vulcan jumps
• Why Alliance Aviation, REA Group, SEEK, & Vulcan shares are charging higher
• Here’s why the Vulcan Energy (ASX:VUL) share price is storming 14% higher

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Vulcan (ASX:VUL) share price slumps despite new partnership appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3qz1UZK

Next week marks one year since the S&P/ASX All Technology Index (ASX: XTX) debuted. Launched at the end of February 2020, the All Technology Index debuted just in time for the March market meltdown.

The index saw its value tumble 42% between launch and the March 2020 low point. But all was not lost — since its March low, the index has regained 159% and is now up 50.5% from its debut, having performed on par with the NASDAQ 100 over the same period. 

The All Technology Index was designed to be representative of Australia’s burgeoning tech sector. Consisting of 46 companies with a combined market capitalisation of over $100 billion on debut, the index now includes 69 companies with a combined market capitalisation of over $170 billion. The top 10 companies in the index, by market capitalisation, are: 

	Company	Market capitalisation
1	Afterpay Ltd (ASX: APT)	$42.26 billion
2	REA Group Limited (ASX: REA)	$20.34 billion
3	Xero Limited (ASX: XRO)	$18.69 billion
4	Seek Limited (ASX: SEK)	$10.94 billion
5	WiseTech Global Ltd (ASX: WTC)	$10.36 billion
6	Computershare Ltd (ASX: CPU)	$7.61 billion
7	Nextdc Ltd (ASX: NXT)	$5.51 billion
8	Carsales.Com Ltd (ASX: CAR)	$5.36 billion
9	Pro Medicus Limited (ASX: PME)	$4.67 billion
10	Altium Limited (ASX: ALU)	$3.82 billion

How have All Technology Index shares performed? 

A number of these names have seen dramatic share price increases over the past year, contributing to the stellar performance on the All Technology Index.

At the time of writing, Afterpay is up 274% over the past year, while REA Group is up 36% and Xero is up 44%. These share price rises have followed impressive performances by these leading ASX technology shares — Afterpay has seen customer numbers nearly double since the All Technology Index debuted. REA Group grew net profit by 13% in the first half of FY21 with the continued recovery in Australian property markets likely to support second half performance. Xero reported a 19% increase in subscriber numbers in its most recent half-year results. 

But it hasn’t all been good news for All Technology Index shares. The index also includes shares such as Webjet Limited (ASX: WEB) and Iress Ltd (ASX: IRE). The Webjet share price is down 46% over the past year as travel bans continue to weigh on the business. The Iress share price is down 28% over the same period with COVID-19 impacting on the timing of projects and revenues relatively flat in the most recent financial reports.

EML Payments Ltd (ASX: EML) has also seen its share price fall over the past year, down 10.7%. The payment solutions provider, which reported largely positive half-year results this week, is one of the most shorted shares on the ASX. 

How is the All Technology Index designed? 

To fully capture the scope of ASX technology businesses, the All Technology Index goes beyond the GICS information technology sector to include other innovative technology related industries. These include healthcare technologies (such as that provided by Pro Medicus) and companies operating online marketplaces that are classified in other GICS sectors.

There is no cap on the number of ASX shares that can be included in the All Technology Index — entrants just need to meet the entry criteria. These criteria cover the percentage of free float shares, market capitalisation, relative liquidity, and minimum daily volume traded. The Index is rebalanced quarterly, with the most recent rebalance occuring in December. 

New additions to the All Technology Index 

In the December rebalance a host of new ASX technology shares were added to the Index. These included Pointerra Limited (ASX: 3DP), 4Dmedical Limited (ASX: 4DX), Bidenergy Limited (ASX: BID), Damstra Holdings Limited (ASX: DTC), Frontier Digital Ventures Limited (ASX: FDV), Family Zone Cyber Safety Limited (ASX: FZO), Harvest Technology Group Ltd (ASX: HTG), Laybuy Group Holdings Limited (ASX: LBY), Marley Spoon Ag (ASX: MMM), Over the Wire Holdings Limited (ASX: OTW), Tesserent Limited (ASX: TNT), Weebit Nano Ltd (ASX: WBT), and Yojeee Limited (ASX: YOJ)

In the preceding September rebalance, Brainchip Holdings Ltd (ASX: BRN), Dicker Data Limited (ASX: DDR), Envirosuite Limited (ASX: EVS), Mach7 Technologies Limited (ASX: M7T), Novonix Limited (ASX: NVX), Splitit Payments Ltd (ASX: SPT), Sezzle Inc (ASX: SZL), and Whispir Limited (ASX: WSP) were added to the index. 

Why do investors choose the All Technology Index? 

The All Technology Index offers a number of benefits for investors. Firstly, it is broader than the previously existing S&P/ASX 200 Information Technology Index, which only includes technology companies in the ASX 200. This means the All Technology Index can provide exposure to smaller businesses that may have greater room for growth.

The index also reaches beyond the GICS information technology sector to include innovative technology based companies included in other sectors. This allows for the inclusion of healthcare technology companies such as Pro Medicus and PainCheck Ltd (ASX: PCK), as well as online marketplaces such as Kogan.com Ltd (ASX: KGN).

What’s next for the All Technology Index? 

The All Technology Index had a shaky start, launching just as the COVID-19 pandemic took hold. But it has proved its resilience over the past year, significantly outperforming the S&P/ASX 200 Index (ASX: XJO). Since its launch, the All Technology Index has gained more than 50%, led by companies such as Afterpay and Kogan. Over the same period, the S&P/ASX 200 is down 1.2%.

The All Technology Index is next due to be rebalanced in March, at which point we may see the number of ASX technology shares included in it increase further. This will provide additional diversification for investors in the index while also providing additional exposure for the companies included in the index.

Whether the All Technology Index can repeat its first year’s performance in its second year remains to be seen, but investors will be keeping their fingers crossed. 

More reading

• Top brokers name 3 ASX shares to buy today
• What’s with the Afterpay (ASX:APT) share price fall today?
• Why Coles, Netwealth, Pro Medicus, & Zip shares are sinking
• ASX 200 down 0.5%: Domino’s delivers, Westpac impresses, Coles sinks
• Why Domino’s, EML Payments, Redbubble, & Westpac shares are storming higher

Kate O’Brien owns shares of Altium. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Damstra Holdings Ltd, EML Payments, Frontier Digital Ventures Ltd, MACH7 FPO, Pro Medicus Ltd., and Whispir Ltd. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Kogan.com ltd, Over The Wire Holdings Ltd, and Pointerra Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. recommends Altium and Sezzle Inc. The Motley Fool Australia owns shares of and has recommended Dicker Data Limited and Webjet Ltd. The Motley Fool Australia owns shares of AFTERPAY T FPO, Altium, WiseTech Global, and Xero. The Motley Fool Australia has recommended carsales.com Limited, Damstra Holdings Ltd, EML Payments, Frontier Digital Ventures Ltd, IRESS Limited, Kogan.com ltd, MACH7 FPO, Over The Wire Holdings Ltd, Pointerra Limited, Pro Medicus Ltd., REA Group Limited, SEEK Limited, Sezzle Inc, and Whispir Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post One year on and 50% up, the All Technology Index is booming appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3jVs9GW

Many of Australia’s top brokers have been busy adjusting their financial models again, leading to the release of a large number of broker notes this week.

Three broker buy ratings that have caught my eye are summarised below. Here’s why brokers think these ASX shares are in the buy zone:

Altium Limited (ASX: ALU)

Analysts at Citi have upgraded this electronic design software company’s shares to a buy rating with an improved price target of $33.50. According to the note, while the broker sees risks to the company achieving its full year guidance, it believes COVID-19 headwinds are easing and demand is improving. It expects this to result in an acceleration in its earnings growth in FY 2022. Citi also believes recent weakness has left its shares trading at an attractive level. The Altium share price is trading at $28.98 today.

Breville Group Ltd (ASX: BRG)

According to a note out of Morgan Stanley, its analysts have retained their overweight rating and increased the price target on this appliance manufacturer’s shares to $35.00. The broker notes that Breville delivered a first half result ahead of its expectations. Looking ahead, Morgan Stanley believes that Breville’s guidance for the full year is conservative and expects it to outperform it. Especially given the strong demand for kitchen appliances. The Breville share price is trading at $30.81 this afternoon.

ELMO Software Ltd (ASX: ELO)

Another note out of Morgan Stanley reveals that its analysts have retained their overweight rating and $9.70 price target on this human resources and payroll platform provider’s shares. This follows the release of its half year results, which were largely pre-released in January. Looking ahead, the broker believes that ELMO is well-placed to achieve the top end of its annualised recurring revenue (ARR) guidance range. The ELMO share price is fetching $6.11 on Wednesday.

More reading

• One year on and 50% up, the All Technology Index is booming
• The latest ASX shares upgraded by brokers to “buy” during the reporting season
• 3 things you might have missed from the Altium (ASX:ALU) half year result
• Here’s why the ELMO (ASX:ELO) share price is surging 6% higher today
• Why the Breville (ASX:BRG) share price is charging 7% higher today

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Elmo Software. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. recommends Altium. The Motley Fool Australia owns shares of Altium. The Motley Fool Australia has recommended Elmo Software. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Top brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3s3lpKi

The Avita Medical Inc (ASX: AVH) share price has stayed in the red today since the company announced its half-year results this morning.

At the time of writing, shares in the regenerative medicine company are down 2.66% at a price of $6.23.

A look at the half-year results

For the half-year ending 31 December 2020, Avita Medical reported a substantial revenue increase from the sale of its goods. Revenue rose to $10.16 million up 56% from the previous corresponding period. However, despite the positive returns, net loss also expanded. The company posted a net loss of $15.87 million, which was up 13% from the first half of FY20.

The widening loss may be weighing on investors’ minds this afternoon as the stock is being sold off. But while shareholders will be regretting the fall, shorters of the stock will be pleased as the company continues its troubled run. Avita Medical remains the eighth most shorted stock on the ASX this week.

Moreover, the company reported a disappointing quarterly report last week, which saw its share price slide 11%. In the report, the company announced a strong cash balance of $59.8 million.

Critically it did not provide guidance to the market due to the prevailing uncertainty stemming from the coronavirus pandemic. The small-cap health share advised that its accounts were highly susceptible to the impacts of COVID-19 because its revenue came predominantly from 20 physicians.

About the Avita Medical share price

Avita Medical is a regenerative medicine company based in the United States. The company’s main offering is Recell, a spray-on treatment used for burn victims. Avita currently boasts a market capitalisation of $136 million.

The Avita share price has had a torrid time of late and is down 63% on the same time last year. The share has not fully recovered from the impacts of COVID-19 and remains some way off its 52-week high of $9.11.

More reading

• How do Avita Medical (ASX:AVH) shares stack up against Polynovo and Aroa Biosurgery?
• These are the 10 most shorted shares on the ASX
• Why AVITA, Baby Bunting, Kathmandu, & Webjet shares are sinking
• The AVITA Medical (ASX: AVH) share price plummets almost 6% in early trade
• Here are the 10 most shorted shares on the ASX

Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Avita Medical Limited. The Motley Fool Australia has recommended Avita Medical Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Why the Avita Medical (ASX:AVH) share price is slipping lower today appeared first on The Motley Fool Australia.

from The Motley Fool Australia https://ift.tt/3qF0sok